ESC 365 - A direct comparison of non-invasive blood markers of liver fibrosis as associates of cardiovascular risk. The Athens cardiometabolic registry

ESC Professional Premium Access

A direct comparison of non-invasive blood markers of liver fibrosis as associates of cardiovascular risk. The Athens cardiometabolic registry

Session: Novel biomarkers for cardiovascular risk prediction

Topic: Biomarkers

Speaker: Doctor S. Athanasopoulos (GR)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Stavros Athanasopoulos

(Greece)

0 follower

5 more presentations in this session

Serum amyloid A-low-density-lipoprotein complex and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX Study

Speaker: Doctor M. Suzuki (Wako, Saitama, JP)

Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in general population: evidence from nhanes 1999-2010

Speaker: Doctor Z. Qiu (Beijing, CN)

Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention

Speaker: Mrs J. Li (Beijing, CN)

Cystatin C predicts cardiovascular events in patients with coronary artery disease both among patients with and among those without type 2 diabetes

Speaker: Associate Professor A. Vonbank (Feldkirch, AT) Doctor A. Mader (Feldkirch, AT)

Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications

Speaker: Doctor J. Liu (Oxford, GB)

Access the full session

Novel biomarkers for cardiovascular risk prediction

Speakers: Doctor S. Athanasopoulos, Doctor M. Suzuki, Doctor Z. Qiu, Mrs J. Li, Associate Professor A. Vonbank...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources